Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Longitudinal outcomes with cancer multigene panel testing in previously tested BRCA1/2 negative patients.

Clinical genetics - 1 Apr 2020

Bradbury Angela R, Egleston Brian L, Patrick-Miller Linda J, Rustgi Neil, Brandt Amanda, Brower Jamie, DiGiovanni Laura, Fetzer Dominique, Berkelbach Christopher, Long Jessica M, Powers Jacquelyn, Stopfer Jill E, Domchek Susan M

Abstract excerpt

Although multigene panel testing (MGPT) is increasingly utilized in clinical practice, there remain limited data on patient-reported outcomes. BRCA 1/2 negative patients were contacted and offered MGPT. Patients completed pre- and posttest counseling, and surveys assessing cognitive, affective and behavioral outcomes at baseline, postdisclosure and 6 and 12 months. Of 317 eligible BRCA1/2 negative patients who...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aged, 80 and over
Share to Biomarkers, Tumor

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to BRCA1 Protein

Share to BRCA2 Protein

Share to Genetic Counseling

Share to Genetic Testing

Share to Neoplasms

Share to Risk Factors

Source

Open in PubMed Open full text

Identifiers

PMID: 32022897
DOI: 10.1111/cge.13716
PMCID: PMC9984207

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Longitudinal outcomes with cancer multigene panel testing in previously tested BRCA1/2 negative patients.PMID 32022897Read ↗

Informing models of cancer genetics care in the era of multigene panel testing with patient-led recommendations.Semantic proximity Read ↗

Clinical and psychological outcomes of receiving a variant of uncertain significance from multigene panel testing or genomic sequencing: a systematic review and meta-analysis.Semantic proximity Read ↗

Beyond BRCA: A Case Series Examining the Advent of Multigene Panel Testing.Semantic proximity Read ↗

Patient feedback and early outcome data with a novel tiered-binned model for multiplex breast cancer susceptibility testing.Semantic proximity Read ↗

Psychosocial outcomes following germline multigene panel testing in an ethnically and economically diverse cohort of patientsSemantic proximity Read ↗

Randomized Noninferiority Trial of Telephone vs In-Person Disclosure of Germline Cancer Genetic Test Results.Semantic proximity Read ↗

Recontact to return new or updated PALB2 genetic results in the clinical laboratory setting.Semantic proximity Read ↗

Longitudinal Changes in Patient Distress following Interactive Decision Aid Use among BRCA1/2 CarriersSemantic proximity Read ↗

Do Breast Cancer Patients Tested in the Oncology Care Setting ShareBRCAMutation Results with Family Members and Health Care Providers?Semantic proximity Read ↗

How should we discuss genetic testing with women newly diagnosed with breast cancer? Design and implementation of a randomized controlled trial of two models of delivering education about treatment-focused genetic testing to younger women newly diagnosed with breast cancer.Semantic proximity Read ↗

Patient-reported outcomes associated with reflex BRCA1/2 tumor and subsequent germline panel genetic testing for high-grade serous ovarian cancer.Semantic proximity Read ↗

Using patient-reported outcomes from the PROCLAIM trial to assess the impact of universal germline genetic testing for prostate cancer patients.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.